Coherus Oncology (CHRS) Return on Sales [ROS] (2013 - 2026)
Coherus Oncology (CHRS) recorded Return on Sales [ROS] of -225.98% in Q2 2026, up 217.61 percentage points from -443.59% a year earlier and up 67.69 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Return on Sales [ROS] (2013 - 2026) Analysis & Trends
On a TTM basis, Coherus Oncology's Return on Sales [ROS] came in at -311.56% as of Jun 30, 2026, up 267.37 percentage points year-over-year; for FY2025, it was -429.51%, up 327.06 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of -462.36 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -756.58% in FY2024 (-677.59 pp), -78.99% in FY2023 (+42.73 pp), -121.72% in FY2022 (-40.92 pp) and -80.80% in FY2021 (-113.65 pp).
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q4 2023.
- On a year-over-year basis, Return on Sales [ROS] has increased for four consecutive quarters, with an average year-over-year change of +272.18 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 2339.14 percentage points in Q1 2025, against a drop of 2728.19 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -293.67% (Q1 2026), -359.90% (Q4 2025) and -383.14% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Coherus Oncology | 119.30 Mn | -516.84 Mn | 10.07 Mn | -225.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -225.98% |
| Mar 31, 2026 | -293.67% |
| Dec 31, 2025 | -359.90% |
| Sep 30, 2025 | -383.14% |
| Jun 30, 2025 | -443.59% |
| Mar 31, 2025 | -597.91% |
| Dec 31, 2024 | -586.89% |
| Sep 30, 2024 | -774.22% |
| Jun 30, 2024 | -384.87% |
| Mar 31, 2024 | -2,937.05% |
| Dec 31, 2023 | -75.29% |
| Sep 30, 2023 | -42.92% |
| Jun 30, 2023 | -58.83% |
| Mar 31, 2023 | -208.86% |
| Dec 31, 2022 | -113.54% |
| Sep 30, 2022 | -177.11% |
| Jun 30, 2022 | -73.17% |
| Mar 31, 2022 | -134.62% |
| Dec 31, 2021 | -53.91% |
| Sep 30, 2021 | -39.74% |
API Access
Coherus Oncology Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();